[Comparative pharmacokinetic analysis based on nonlinear mixed effect model].

Area of Science:

• Pharmacokinetics
• Drug Development
• Clinical Trial Design

Background:

• Comparative pharmacokinetic (PK) analysis is crucial for drug development, assessing equivalence between treatments using parameters like AUC and Cmax.
• Traditional non-compartmental analysis struggles with sparsely sampled data, common in clinical trials.
• Nonlinear mixed-effects modeling (NONMEM) offers a potential solution for analyzing such limited PK data.

Purpose of the Study:

• To evaluate the reliability of NONMEM for analyzing sparsely sampled pharmacokinetic data in comparative studies.
• To compare PK parameter estimates derived from sparse data analyzed by NONMEM against dense data analyzed by non-compartmental methods.

Main Methods:

• Simulated a sparse sampling design trial using dense sampling data from a comparative PK study.
• Analyzed sparse data using the NONMEM method.
• Analyzed original dense data using conventional non-compartmental analysis.

Main Results:

• Despite different trial designs and analysis methods, 90% confidence intervals for PK parameter ratios were very similar between NONMEM and non-compartmental analysis.
• Bootstrap analysis (n=1000) supported the similarity of results.

Conclusions:

• NONMEM is a reliable method for analyzing sparse data in comparative pharmacokinetic studies.
• This approach enables robust PK assessment even when individual data points are limited.